Adhd and Hyperacusis
Summary:
Hyperacusis is found among people with Adhd, especially for people who are male, 10-19 old.
The study analyzes which people have Hyperacusis with Adhd. It is created by eHealthMe based on reports of 94 people who have Adhd from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Adhd?
Adhd (adhd-mental disorders that develop in children) is found to be associated with 601 drugs and 1,371 conditions by eHealthMe. Check the latest studies of Adhd.
What is Hyperacusis?
Hyperacusis (disorder in loudness perception) is found to be associated with 462 drugs and 600 conditions by eHealthMe. Check the latest studies of Hyperacusis.
94 people who have Adhd and Hyperacusis are studied.

Gender of people who have Adhd and experienced Hyperacusis *:
- female: 41.76 %
- male: 58.24 %
Age of people who have Adhd and experienced Hyperacusis *:
- 0-1: 0.0 %
- 2-9: 24.69 %
- 10-19: 25.93 %
- 20-29: 7.41 %
- 30-39: 17.28 %
- 40-49: 11.11 %
- 50-59: 11.11 %
- 60+: 2.47 %
Common co-existing conditions for these people *:
- Depression: 5 people, 5.32%
- Stress And Anxiety: 2 people, 2.13%
- Quit Smoking: 2 people, 2.13%
- Bipolar Disorder (mood disorder): 2 people, 2.13%
- Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 2 people, 2.13%
- Neuralgia (pain in one or more nerves): 2 people, 2.13%
- Breast Cancer: 2 people, 2.13%
- Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 1.06%
- Anger: 1 person, 1.06%
- Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 1 person, 1.06%
Common drugs taken by these people *:
- Strattera: 19 people, 20.21%
- Vyvanse: 15 people, 15.96%
- Concerta: 15 people, 15.96%
- Ritalin: 10 people, 10.64%
- Daytrana: 6 people, 6.38%
- Lisdexamfetamine Dimesylate: 5 people, 5.32%
- Abilify: 4 people, 4.26%
- Vitamin C: 4 people, 4.26%
- Qelbree: 4 people, 4.26%
- Vitamin D: 4 people, 4.26%
Common symptoms for these people *:
- Stress And Anxiety: 22 people, 23.40%
- Headache (pain in head): 21 people, 22.34%
- Disturbance In Attention: 15 people, 15.96%
- Fatigue (feeling of tiredness): 15 people, 15.96%
- Feeling Abnormal: 15 people, 15.96%
- Nausea (feeling of having an urge to vomit): 14 people, 14.89%
- Photophobia (extreme sensitivity to light): 14 people, 14.89%
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 13 people, 13.83%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 12 people, 12.77%
- Depression: 11 people, 11.70%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hyperacusis?
Check whether Hyperacusis is associated with a drug or a conditionRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Adhd (120,225 reports)
- Hyperacusis (4,388 reports)
All the drugs that are associated with Hyperacusis:
- Hyperacusis (462 drugs)
All the conditions that are associated with Hyperacusis:
- Hyperacusis (600 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hyperacusis and Adhd, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zofran cause Granulomatous Liver Disease? - a second ago
- Coreg and Deep Vein Thrombosis for Men aged 50-59 - 2 seconds ago
- Coreg and Dvt for Men aged 50-59 - 2 seconds ago
- Coreg and Blood Clot In The Legs for Men aged 50-59 - 2 seconds ago
- Coreg and Deep Venous Thrombosis for Men aged 50-59 - 3 seconds ago
- Vicoprin vs. Codeine, Aspirin, Apap Formula No. 4, side effect and effectiveness comparison - 14 seconds ago
- Amlodipine and Atorvastatin Calcium drug interactions for women aged 50-59 - 18 seconds ago
- Could Asa cause Aortic Valve Incompetence? - 20 seconds ago
- Deep Venous Thrombosis and drugs of ingredients of carvedilol - 30 seconds ago
- Could Olmesartan Medoxomil cause Deep Venous Thrombosis? - 35 seconds ago